Loading company…
Resilient Biotics develops microbiome-based treatments intended to reduce or replace antibiotics in animal health.
Founded in 2016 and based in Durham, US, Resilient Biotics develops live biotherapeutics for animal health. Its RBX001 product is an intranasal, non-antibiotic treatment for bovine respiratory disease. The company is also exploring microbiome-derived treatments for swine, poultry and other animals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in